跳至主要内容
临床试验/CTRI/2024/04/065025
CTRI/2024/04/065025尚未招募2 期

Efficacy of two different doses of oral ivabradine for attenuation of hemodynamic response to laryngoscopy and endotracheal intubation-a randomized controlled trial

Mulagapaka Raghuram Naidu1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2024年4月10日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
140
试验地点
1
主要终点
1)To measure heart rate 1 minute after intubation.

研究概览

简要总结

.Ivabradine is a very unique cardiotonic drug, it reduces the heart rate without hemodynamic changes

.Ivabradine inhibits the funny current (“If” channels) in sinoatrial nodal tissue that leads to decrease in the rate of diastolic depolarisation and consequently   decreases heart rate without affecting blood pressure

.previous studies have shown at this doses (2.5mg and 5mg)of oral ivabradine decreases response to laryngoscopy and endotracheal intubation

.we assume that oral ivabradine at lower doses can attenuate the hemodynamic response to laryngoscopy and endotracheal intubation

Primary objective***:***

To estimate the efficacy of two different doses (2.5mg and 5 mg) of oral ivabradine for attenuation of hemodynamic response during laryngoscopy and intubation

Secondary objective:

To estimate incidence of side effects of ivabradine: bradycardia, visual disturbances like luminous phenomenon.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patients posted for elective surgeries under general anaesthesia 2)Mallampati grade 1 and 2 patients 3)American Society of Anaesthesiologists (ASA)I,II.

排除标准

  • 1.Heart rate less than 60 beats per min and SBP less than 100 mmhg 2.Sick sinus syndrome, Ecg abnormalities, visual disturbances.
  • 3.Calcium channel blockers, azoles, antifungals, antiretroviral drugs and macrolides 4.pregnancy and lactating females 5.Difficult Intubation and laryngoscopy more than 15 seconds.

结局指标

主要结局

1)To measure heart rate 1 minute after intubation.

时间窗: 1minute

次要结局

  • 1)To measure heart rate 3min, 5min, 8min and 10 min after intubation.(2)To measure SBP, DBP, MAP after 1min, 3min,5min,8min,10min after intubation.)

研究者

发起方
Mulagapaka Raghuram Naidu
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Mulagapaka Raghuram Naidu

kalinga institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验